Insider Transactions in Q2 2024 at Olema Pharmaceuticals, Inc. (OLMA)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2024
|
Cyrus Harmon |
SELL
Open market or private sale
|
Direct |
20,000
-2.56%
|
$200,000
$10.77 P/Share
|
|
Jun 04
2024
|
G. Walmsley Graham Director |
SELL
Open market or private sale
|
Indirect |
1,175,000
-45.06%
|
$16,450,000
$14.85 P/Share
|
|
Jun 04
2024
|
Cyrus Harmon |
SELL
Open market or private sale
|
Direct |
5,000
-0.64%
|
$60,000
$12.33 P/Share
|
|
Jun 03
2024
|
Cyrus Harmon |
SELL
Open market or private sale
|
Direct |
5,000
-0.63%
|
$50,000
$10.93 P/Share
|
|
May 31
2024
|
Cyrus Harmon |
SELL
Open market or private sale
|
Direct |
15,000
-1.86%
|
$135,000
$9.41 P/Share
|
|
May 24
2024
|
Naseem Zojwalla CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
9,460
+9.53%
|
$37,840
$4.87 P/Share
|
|
May 06
2024
|
Cyrus Harmon |
SELL
Open market or private sale
|
Direct |
5,000
-0.62%
|
$50,000
$10.92 P/Share
|
|
Apr 30
2024
|
Cyrus Harmon |
SELL
Open market or private sale
|
Direct |
15,000
-1.82%
|
$135,000
$9.51 P/Share
|